Literature DB >> 22938129

A no-fault compensation system for medical injury is long overdue.

David Weisbrot1, Kerry J Breen.   

Abstract

The 2011 report of the Productivity Commission (PC) recommended the establishment of a no-fault national injury insurance scheme limited to "catastrophic" injury, including medical injury. The report is welcome, but represents a missed opportunity to establish simultaneously a much-needed no-fault scheme for all medical injuries. The existing indemnity scheme based on negligence remains a slow, costly, inefficient, ill targeted and stress-creating system. A fault-based negligence scheme cannot deter non-intentional errors and does little to identify or prevent systems failures. In addition, it discourages reporting, and thus is antithetical to the modern focus on universal patient safety. A no-fault scheme has the potential to be fairer, quicker and no more costly, and to contribute to patient safety. No-fault schemes have been in place in at least six developed countries for many years. This extensive experience in comparable countries should be examined to assist Australia to design an effective, comprehensive system. Before implementing the recommendations of the PC, the federal government should ask the Commission to study and promptly report on an ancillary no-fault scheme that covers all medical injury.

Entities:  

Mesh:

Year:  2012        PMID: 22938129     DOI: 10.5694/mja12.10322

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Compensation for clinical trial-related injury and death in India: challenges and the way forward.

Authors:  Yogendra Kumar Gupta; Arun Kumar Pradhan; Aman Goyal; Prafull Mohan
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

2.  Injury and death in clinical trials and compensation: Rule 122 DAB.

Authors:  Ravindra B Ghooi
Journal:  Perspect Clin Res       Date:  2013-10

3.  Study protocol: developing a decision system for inclusive housing: applying a systematic, mixed-method quasi-experimental design.

Authors:  Heidi Zeeman; Elizabeth Kendall; Jennifer A Whitty; Courtney J Wright; Clare Townsend; Dianne Smith; Ali Lakhani; Samantha Kennerley
Journal:  BMC Public Health       Date:  2016-03-15       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.